| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |